Cargando…

New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention

The recent outbreak of SARS-CoV-2 resulted into the deadly COVID-19 pandemic, which has made a profound impact on mankind and the world health care system. SARS-CoV-2 is mainly transmitted within the population via symptomatic carriers, enters the host cell via ACE2 and TMPSSR2 receptors and damages...

Descripción completa

Detalles Bibliográficos
Autores principales: Solanki, R., Shankar, A., Modi, U., Patel, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981536/
https://www.ncbi.nlm.nih.gov/pubmed/36950312
http://dx.doi.org/10.1016/j.mtchem.2023.101478
_version_ 1784900125519249408
author Solanki, R.
Shankar, A.
Modi, U.
Patel, S.
author_facet Solanki, R.
Shankar, A.
Modi, U.
Patel, S.
author_sort Solanki, R.
collection PubMed
description The recent outbreak of SARS-CoV-2 resulted into the deadly COVID-19 pandemic, which has made a profound impact on mankind and the world health care system. SARS-CoV-2 is mainly transmitted within the population via symptomatic carriers, enters the host cell via ACE2 and TMPSSR2 receptors and damages the organs. The standard diagnostic tests and treatment methods implemented lack required efficiency to beat SARS-CoV-2 in the race of its spreading. The most prominently used diagnostic test,reverse transcription-polymerase chain reaction (a nucleic acid-based method), has limitations including a prolonged time taken to reveal results, limited sensitivity, a high rate of false negative results, and lacking specificity due to a homology with other viruses. Furthermore, as part of the treatment, antiviral drugs such as remdesivir, favipiravir, lopinavir/ritonavir, chloroquine, daclatasvir, atazanavir, and many more have been tested clinically to check their potency for the treatment of SARS-CoV-2 but none of these antiviral drugs are the definitive cure or suitable prophylaxis. Thus, it is always required to combat SARS-CoV-2 spread and infection for a better and precise prognosis. This review answers the above mentioned challenges by employing nanomedicine for the development of improved detection, treatment, and prevention strategies for SARS-CoV-2. In this review, nanotechnology-based detection methods such as colorimetric assays, photothermal biosensors, molecularly imprinted nanoparticles sensors, electrochemical nanoimmunosensors, aptamer-based biosensors have been discussed. Furthermore, nanotechnology-based treatment strategies involving polymeric nanoparticles, metallic nanoparticles, lipid nanoparticles, and nanocarrier-based antiviral siRNA delivery have been depicted. Moreover, SARS-CoV-2 prevention strategies, which include the nanotechnology for upgrading personal protective equipment, facemasks, ocular protection gears, and nanopolymer-based disinfectants, have been also reviewed. This review will provide a one-site informative platform for researchers to explore the crucial role of nanomedicine in managing the COVID-19 curse more effectively.
format Online
Article
Text
id pubmed-9981536
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-99815362023-03-03 New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention Solanki, R. Shankar, A. Modi, U. Patel, S. Mater Today Chem Article The recent outbreak of SARS-CoV-2 resulted into the deadly COVID-19 pandemic, which has made a profound impact on mankind and the world health care system. SARS-CoV-2 is mainly transmitted within the population via symptomatic carriers, enters the host cell via ACE2 and TMPSSR2 receptors and damages the organs. The standard diagnostic tests and treatment methods implemented lack required efficiency to beat SARS-CoV-2 in the race of its spreading. The most prominently used diagnostic test,reverse transcription-polymerase chain reaction (a nucleic acid-based method), has limitations including a prolonged time taken to reveal results, limited sensitivity, a high rate of false negative results, and lacking specificity due to a homology with other viruses. Furthermore, as part of the treatment, antiviral drugs such as remdesivir, favipiravir, lopinavir/ritonavir, chloroquine, daclatasvir, atazanavir, and many more have been tested clinically to check their potency for the treatment of SARS-CoV-2 but none of these antiviral drugs are the definitive cure or suitable prophylaxis. Thus, it is always required to combat SARS-CoV-2 spread and infection for a better and precise prognosis. This review answers the above mentioned challenges by employing nanomedicine for the development of improved detection, treatment, and prevention strategies for SARS-CoV-2. In this review, nanotechnology-based detection methods such as colorimetric assays, photothermal biosensors, molecularly imprinted nanoparticles sensors, electrochemical nanoimmunosensors, aptamer-based biosensors have been discussed. Furthermore, nanotechnology-based treatment strategies involving polymeric nanoparticles, metallic nanoparticles, lipid nanoparticles, and nanocarrier-based antiviral siRNA delivery have been depicted. Moreover, SARS-CoV-2 prevention strategies, which include the nanotechnology for upgrading personal protective equipment, facemasks, ocular protection gears, and nanopolymer-based disinfectants, have been also reviewed. This review will provide a one-site informative platform for researchers to explore the crucial role of nanomedicine in managing the COVID-19 curse more effectively. Elsevier Ltd. 2023-04 2023-03-03 /pmc/articles/PMC9981536/ /pubmed/36950312 http://dx.doi.org/10.1016/j.mtchem.2023.101478 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Solanki, R.
Shankar, A.
Modi, U.
Patel, S.
New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention
title New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention
title_full New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention
title_fullStr New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention
title_full_unstemmed New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention
title_short New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention
title_sort new insights from nanotechnology in sars-cov-2 detection, treatment strategy, and prevention
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981536/
https://www.ncbi.nlm.nih.gov/pubmed/36950312
http://dx.doi.org/10.1016/j.mtchem.2023.101478
work_keys_str_mv AT solankir newinsightsfromnanotechnologyinsarscov2detectiontreatmentstrategyandprevention
AT shankara newinsightsfromnanotechnologyinsarscov2detectiontreatmentstrategyandprevention
AT modiu newinsightsfromnanotechnologyinsarscov2detectiontreatmentstrategyandprevention
AT patels newinsightsfromnanotechnologyinsarscov2detectiontreatmentstrategyandprevention